---
{"dg-publish":true,"permalink":"/USMLE/MSK/Systemic sclerosis/"}
---

# Epidemiology
- ♀ > ♂ (∼ 5:1)
- Peak incidence: 30–50 years

---
# Etiology


---
# Pathophysiology
Systemic sclerosis (SSc) is a systemic autoimmune disease characterized by <span style="background:rgba(240, 200, 0, 0.2)">vasculopathy and fibrosis</span> of the skin and other organs.![highresdefault_L83817.jpg](/img/user/appendix/highresdefault_L83817.jpg)

---
# Clinical features

| Category           | Limited Cutaneous                                                                                                       | Diffuse Cutaneous                                                                |
| ------------------ | ----------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------- |
| **Manifestations** | Distal sclerosis (most prominent in the fingers), <span style="background:rgba(240, 200, 0, 0.2)">CREST syndrome</span> | Proximal sclerosis (involves the trunk & proximal extremities)                   |
| **Serology**       | Anticentromere                                                                                                          | Anti–Scl-70                                                                      |
| **Complications**  | [[USMLE/Respiratory/Pulmonary hypertension\|Pulmonary hypertension]], Scleroderma renal crisis                                                                        | <span style="background:rgba(240, 200, 0, 0.2)">[[USMLE/Respiratory/Interstitial lung diseases\|Interstitial lung disease]]</span> |
## CREST syndrome
CREST syndrome refers to a constellation of symptoms traditionally associated with <span style="background:rgba(240, 200, 0, 0.2)">limited SSc</span> (can also be seen in diffuse SSc).
- C: Calcinosis cutis: small white calcium deposits on the pressure points of the extremities (e.g., elbows, knees, fingertips) ![Pasted image 20231010172910.png](/img/user/appendix/Pasted%20image%2020231010172910.png)
- R: Raynaud phenomenon 
- <span style="background:rgba(240, 200, 0, 0.2)">E: Esophageal hypomotility</span> (systemic sclerosis): <span style="background:rgba(240, 200, 0, 0.2)">smooth muscle atrophy and fibrosis → esophageal dysmotility and decreased lower esophageal sphincter pressure → dysphagia, gastroesophageal reflux, heartburn → aspiration, Barrett esophagus, stricture.</span> See [[USMLE/GI/Esophageal motility disorders\|Esophageal motility disorders]]
- S: Sclerodactyly ![Pasted image 20231010201149.png](/img/user/appendix/Pasted%20image%2020231010201149.png)
- T: Telangiectasia![Pasted image 20231010201224.png](/img/user/appendix/Pasted%20image%2020231010201224.png)
## Cutaneous
- <span style="background:rgba(240, 200, 0, 0.2)">Thickening and hardening of the skin, which appears smooth, shiny, and puffy</span>
- <span style="background:rgba(240, 200, 0, 0.2)">Sclerodactyly</span>: fibrotic thickening and tightening of the skin on the fingers and hands 
	- Edema followed by fibrosis that results in a waxy appearance of the skin
	- Limited range of motion and possibly flexure contractures and clawing of the digits
	- Multiple, painful ischemic digital ulcers with atrophy and necrotic spots
	- Digital pitting: hyperkeratotic scarring that most commonly affects the fingertips![Pasted image 20231010201323.png](/img/user/appendix/Pasted%20image%2020231010201323.png)
- Face changes
	- Loss of expression (mask-like facies) 
	- Smoothing of deep wrinkles
	- Microstomia (a disproportionately small mouth) accompanied by characteristic perioral wrinkles
## Renal
- <span style="background:rgba(240, 200, 0, 0.2)">Scleroderma renal crisis (SRC)</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">Abrupt onset, life threatening</span>
	- SRC is caused by immune-mediated injury to <span style="background:rgba(240, 200, 0, 0.2)">small renal vessels that typically spares the glomerular capillaries</span>
	- Clinical features of SRC
		- <span style="background:rgba(240, 200, 0, 0.2)">Oliguric [[USMLE/Renal/Acute kidney injury\|acute kidney injury]], proteinuria, hematuria</span>
		- <span style="background:rgba(240, 200, 0, 0.2)">[[USMLE/Cardiology/Hypertension\|Hypertension]] with or without symptoms of hypertensive emergency</span>
		- Microangiopathic hemolytic [[USMLE/Blood/Anemia\|anemia]] (<span style="background:rgba(240, 200, 0, 0.2)">MAHA</span>) and thrombocytopenia
	- Treatment: ACE inhibitors
- [[USMLE/Renal/Chronic kidney disease\|Chronic kidney disease]]: reduced kidney function due to abnormal [[USMLE/Biochemistry/Extracellular matrix\|collagen]] deposition → thickening of renal arteriolar walls → decreased renal blood flow
## Pulmonary
- <span style="background:rgba(240, 200, 0, 0.2)">[[USMLE/Respiratory/Interstitial lung diseases\|Interstitial lung disease]] </span>
- Pulmonary artery [[USMLE/Cardiology/Hypertension\|hypertension]] 
## Other extracutaneous
- Gastrointestinal tract
	- Esophageal dysmotility → dysphagia and reflux
	- <span style="background:rgba(240, 200, 0, 0.2)">Small bowel dysmotility → bloating, gas, constipation, and cramping </span>
		- <span style="background:rgba(240, 200, 0, 0.2)">Dysmotility creates an ideal environment for bacterial overgrowth.</span>
		- <span style="background:rgba(240, 200, 0, 0.2)">[[USMLE/GI/Small intestinal bacterial overgrowth\|Small intestinal bacterial overgrowth]]</span>
- Vascular disease
	- Raynaud phenomenon 
	- Thromboembolism

---
# Diagnostics
>[!warning] 
><span style="background:rgba(240, 200, 0, 0.2)">Scleroderma renal crisis is a medical emergency</span> with a high mortality rate. Promptly evaluate serum creatinine and urine protein in individuals with SSc who present with an acute rise in blood pressure and start management of SRC.
- Antinuclear antibodies (ANA): present in ∼ 90% of patients
- SSc-specific autoantibodies![Pasted image 20240116151535.png](/img/user/appendix/Pasted%20image%2020240116151535.png)

	- <span style="background:rgba(240, 200, 0, 0.2)">Anticentromere antibodies</span>: associated with limited SSc, increased risk for vascular complications (e.g., PAH)
	- <span style="background:rgba(240, 200, 0, 0.2)">Anti-SCl-70 (anti-topoisomerase I antibody)</span>: associated with severe and rapidly progressive diffuse SSc, limited SSc, ILD, digital ulcers
	- <span style="background:rgba(240, 200, 0, 0.2)">Anti-RNA polymerase III</span>: associated with diffuse SSc, scleroderma renal crisis
- A characteristic skin biopsy finding is <span style="background:rgba(240, 200, 0, 0.2)">dermal layer expansion </span>due to diffuse deposition of [[USMLE/Biochemistry/Extracellular matrix\|collagen]] (eosinophilic connective tissue), resulting in <span style="background:rgba(240, 200, 0, 0.2)">atrophy of the intradermal adipose tissue and dermal appendages (ie, hair follicles, glands).</span>![L4543.jpg](/img/user/appendix/L4543.jpg)

# Differential diagnostics
---

<div class="transclusion internal-embed is-loaded"><a class="markdown-embed-link" href="/USMLE/MSK/Idiopathic inflammatory myopathies/#dermatomyositis-vs-systemic-sclerosis" aria-label="Open link"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-link"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a><div class="markdown-embed">



## Dermatomyositis vs. Systemic Sclerosis

| **Feature**       | **Dermatomyositis (DM)**                                                                                     | **Systemic Sclerosis (SSc)**                                                                                             |
| ----------------- | ------------------------------------------------------------------------------------------------------------ | ------------------------------------------------------------------------------------------------------------------------ |
| **Primary Issue** | Muscle & skin inflammation (capillary damage)                                                                | Widespread **fibrosis** & vasculopathy                                                                                   |
| **Key Skin**      | **Gottron's papules**, **Heliotrope rash**, Shawl/V-sign, Mechanic's hands                                   | **Skin thickening/tightening (scleroderma)**, Sclerodactyly, Telangiectasias, Calcinosis, Raynaud's (often first)        |
| **Muscle**        | <span style="background:rgba(240, 200, 0, 0.2)">**Symmetric proximal weakness** (prominent), myalgias</span> | <span style="background:rgba(240, 200, 0, 0.2)">Often mild or late; arthralgias/tendon rubs more common</span>           |
| **Key Organ**     | **Interstitial Lung Disease (ILD)**, dysphagia (skeletal muscle)                                             | **ILD**, **Pulmonary Arterial Hypertension (PAH)**, Esophageal dysmotility (smooth muscle), **Scleroderma Renal Crisis** |
| **Antibodies**    | **Anti-Jo-1** (ILD), **Anti-Mi-2** (classic skin), Anti-MDA5 (amyopathic, severe ILD), Anti-TIF1-γ (cancer)  | **Anti-Scl-70** (diffuse, ILD), **Anti-centromere** (limited/CREST, PAH), Anti-RNA Pol III (renal crisis)                |
| **Malignancy**    | **High risk** (ovary, lung, etc.)                                                                            | Slight increase (e.g., lung with ILD)                                                                                    |
| **Tx Pearl**      | Corticosteroids, immunosuppressants; **Cancer screening crucial**                                            | Organ-based; **ACE Inhibitors for Renal Crisis (VITAL!)**                                                                |
| **Subtype/Note**  | Amyopathic DM (skin, no weakness)                                                                            | Limited (CREST) vs. Diffuse variants                                                                                     |

</div></div>

# Treatment


---
